Phase II/III Study of Fluorouracil (5-FU) and its Modulation in Advanced Colorectal Cancer
Publication Information Expand/Collapse
PMid: PMID29370458 | PMC number: PMC5963502
Survival by Hispanic Ethnicity Among Cancer Patients participating in SWOG Clinical Trials
Differences in toxicity between men and women treated with 5-fluorouracil therapy for colorectal carcinoma
Phase II study of fluorouracil and its modulation in advanced colorectal cancer: A Southwest Oncology Group study
Fluorouracil (5-FU) schedules and modulation in advanced colorectal cancer (CRC): A Southwest Oncology Group screening trial.
Selection designs for pilot studies based on survival.